Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

GP Healthcare Capital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 12
Average round size
info
The average size of a deal this fund participated in
$30M
Portfolio companies 12
Rounds per year 1.33
Lead investments 1
Exits 2
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Manufacturing
Summary

In 2015 was created GP Healthcare Capital, which is appeared as VC. The leading representative office of defined VC is situated in the Shanghai. The venture was found in Asia in China.

The common things for fund are deals in the range of 10 - 50 millions dollars. Comparing to the other companies, this GP Healthcare Capital performs on 9 percentage points less the average number of lead investments. Considering the real fund results, this VC is 20 percentage points more often commits exit comparing to other organizations. The top amount of exits for fund were in 2016. The fund is constantly included in less than 2 investment rounds annually. The high activity for fund was in 2016.

The fund has specific favorite in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Among the most popular fund investment industries, there are Therapeutics, Medical Device. Among the various public portfolio startups of the fund, we may underline Adagene, MicuRx Pharmaceuticals, Beijing Allcure Medical Technology Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China.

The typical case for the fund is to invest in rounds with 2-3 participants. Despite the GP Healthcare Capital, startups are often financed by Morningside Group, WuXi Healthcare Ventures, MAGS Capital. The meaningful sponsors for the fund in investment in the same round are WuXi Healthcare Ventures, Trustbridge Partners, TitanMed Capital. In the next rounds fund is usually obtained by Sequoia Capital China, New World TMT Ltd, King Star Capital.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of GP Healthcare Capital:
Typical Co-investors
GP Healthcare Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after GP Healthcare Capital:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Aota Touzi China, Guangdong, Shenzhen
Beyond Black Berlin, Berlin, Germany
Blue Horizon Corporation Switzerland, Zürich, Zurich
CampVentures California, Los Altos, United States
Chuangjin Ziben Beijing, Beijing, China
Early Capital -
Gordon Food Service Grand Rapids, Michigan, United States
Greenland Hong Kong Holdings Limited China, Shanghai
Macro California, Los Angeles, United States
OCA Ventures Chicago, Illinois, United States
Oklahoma Life Science Fund Oklahoma, Tulsa, United States
Optimist Capital -
Oracle California, Redwood Shores, United States
Purify -
SDIC Venture Capital China, Hebei, Xicheng
Seed Fond Aachen Aachen, Germany, Nordrhein-Westfalen
VCF III -
VivaKi Chicago, Illinois, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Stand Group

Biotechnology
Consulting
Test and Measurement
27 Jul 2023 Qingdao Shi, Shandong, China

Kingwills New Materials

Advanced Materials
Manufacturing
$15M18 May 2023 Shanghai, Shanghai, China

Lingyu Technology

Digital Marketing
Financial Services
FinTech
28 Nov 2022 Jiangxi, Guangdong, China

Yuntian Semiconductor

Electronics
Manufacturing
Semiconductor
06 Dec 2021 Xiamen, China

Laekna Therapeutics

Biotechnology
$27M02 Apr 2019 Shanghai, China

GenomiCare Biotechnology

Biotechnology
$30M18 Dec 2018 China, Shanghai

Beijing Allcure Medical Technology

Cloud Computing
Health Care
Medical
Therapeutics
$108M24 Jul 2018 China, Beijing

MicuRx Pharmaceuticals

Biotechnology
Health Care
Medical
$55M26 Sep 2016 Hayward, California, United States

Adagene

Biotechnology
Medical
Therapeutics
$28M29 Jan 2016 Gusu District, Jiangsu, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent GP Healthcare Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 12
Average round size 30M
Rounds per year 1.33
Peak activity year 2021
Lead investments 1
Exits 2
Group Appearance index 0.92

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Stand Group

Biotechnology
Consulting
Test and Measurement
27 Jul 2023 Qingdao Shi, Shandong, China

Kingwills New Materials

Advanced Materials
Manufacturing
$15M18 May 2023 Shanghai, Shanghai, China

Lingyu Technology

Digital Marketing
Financial Services
FinTech
28 Nov 2022 Jiangxi, Guangdong, China

Yuntian Semiconductor

Electronics
Manufacturing
Semiconductor
06 Dec 2021 Xiamen, China

Laekna Therapeutics

Biotechnology
$27M02 Apr 2019 Shanghai, China

GenomiCare Biotechnology

Biotechnology
$30M18 Dec 2018 China, Shanghai

Beijing Allcure Medical Technology

Cloud Computing
Health Care
Medical
Therapeutics
$108M24 Jul 2018 China, Beijing

MicuRx Pharmaceuticals

Biotechnology
Health Care
Medical
$55M26 Sep 2016 Hayward, California, United States

Adagene

Biotechnology
Medical
Therapeutics
$28M29 Jan 2016 Gusu District, Jiangsu, China
Crunchbase icon

Content report

The following text will be sent to our editors: